Nan Lv

Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Journal: Seminars in oncology
Published: September 20, 2025

Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting.

Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting.

Journal: BMC cancer
Published: March 27, 2025

Pyogenic liver abscess following biliary stent placement in pancreatic cancer patients: a retrospective case series.

Pyogenic liver abscess following biliary stent placement in pancreatic cancer patients: a retrospective case series.

Journal: BMC cancer
Published: February 13, 2025

The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal drainage post-surgery: a retrospective cohort study.

The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal drainage post-surgery: a retrospective cohort study.

Journal: BMC cancer
Published: February 11, 2025

Trends in 5-year cancer survival disparities by race and ethnicity in the US between 2002-2006 and 2015-2019.

Trends in 5-year cancer survival disparities by race and ethnicity in the US between 2002-2006 and 2015-2019.

Journal: Scientific reports
Published: April 26, 2024

Unlocking the High Capacity Ammonium-Ion Storage in Defective Vanadium Dioxide.

Unlocking the High Capacity Ammonium-Ion Storage in Defective Vanadium Dioxide.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 10, 2022

Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281].

Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281].

Journal: Cancer letters
Published: December 31, 2018

Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP-2 gelatinolytic activity via ERK- and PI3K-dependent signalling.

Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP-2 gelatinolytic activity via ERK- and PI3K-dependent signalling.

Journal: Cell proliferation
Published: October 24, 2018

Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.

Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.

Journal: Molecular cancer
Published: August 30, 2016

Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.

Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.

Journal: Cancer letters
Published: August 13, 2016

Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expression.

Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expression.

Journal: Molecular medicine reports
Published: February 21, 2014

CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.

CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.

Journal: International journal of oncology
Published: April 28, 2013
Showing 1-12 of 15

Last Updated: 09/26/2026